Overview
- 89 inspections across 65 sites are on record.
- 257 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-06-11.
At a glance
Inspections
89
Sites
65
Observations
257
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11 Jun 2019 | Human Drugs | View 483 → |
| Kashiv BioSciences, LLC | 12 Mar 2019 | Human Drugs | On file |
| DEVA HOLDING ANONIM SIRKETI - CERKEZKOY SUBESI | 15 Feb 2019 | Human Drugs | View 483 → |
| Cipla Limited | 28 Sep 2018 | Human Drugs | On file |
| CATALENT U.K. SWINDON ZYDIS LIMITED | 20 Apr 2018 | Human Drugs | View 483 → |
Sites inspected
Sun Pharmaceutical Industries Ltd.Halol, India1 insp.
Kashiv BioSciences, LLCChicago, United States1 insp.
DEVA HOLDING ANONIM SIRKETI - CERKEZKOY SUBESIKapakli, Turkey1 insp.
Cipla LimitedSalcette, India1 insp.
CATALENT U.K. SWINDON ZYDIS LIMITEDSwindon, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey D Meng9 shared
Emily J Orban7 shared
Steven A Gonzales7 shared
Andrew J Idzior6 shared
Sarah M Napier6 shared
Robert M Barbosa5 shared
Michele L Forster5 shared
Patsy J Domingo5 shared
Sanket N Patel4 shared
Caroline H Le4 shared
Full investigator report
Get the verbatim findings behind Rebecca E Dombrowski's 257 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site